COMMUNIQUÉS West-GlobeNewswire
-
Saniona AB: Saniona AB's Nomination Committee for the 2018 Annual General Meeting
23/11/2017 - 08:01 -
THIRD GLOBAL IRON DEFICIENCY DAY TO RAISE AWARENESS OF THE SYMPTOMS OF IRON DEFICIENCY
23/11/2017 - 07:01 -
Probiodrug : Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017
23/11/2017 - 07:00 -
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017
22/11/2017 - 23:00 -
Forward Pharma Announces Completion of Corporate Restructuring Plan
22/11/2017 - 22:30 -
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
22/11/2017 - 22:30 -
RedHawk Announces First Quarter Results
22/11/2017 - 22:30 -
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22/11/2017 - 22:15 -
TESARO Announces Participation in Two Investor Conferences
22/11/2017 - 22:05 -
Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference
22/11/2017 - 22:05 -
Adamas to Present at Two Upcoming Investor Conferences
22/11/2017 - 18:42 -
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor
22/11/2017 - 18:19 -
GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT
22/11/2017 - 18:19 -
Innate Pharma provides an update on Lirilumab
22/11/2017 - 17:46 -
Innate Pharma annonce une mise à jour du programme Lirilumab
22/11/2017 - 17:46 -
Sienna Senior Living named one of Canada’s Most Admired Corporate Cultures for 2017
22/11/2017 - 17:44 -
Analogic Announces Timing for First Quarter 2018 Earnings Conference Call and Webcast
22/11/2017 - 17:00 -
Axim Biotechnologies Reports Third Quarter 2017 Results
22/11/2017 - 16:00 -
Dr. Robert M. Taft Installed as President of the American College of Prosthodontists
22/11/2017 - 15:27
Pages